Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and prognosis of Alzheimer’s disease. Studies by teams from Boston University and other institutions demonstrate that blood-based microRNAs can predict the progression from mild cognitive impairment to dementia and could align with existing Alzheimer’s biomarkers for earlier intervention. Alzheimer’s […]
Source link